As previously reported, BofA/Merrill downgraded LifePoint to Underperform from Neutral. Analyst Kevin Fischbeck said the Trump victory and Republican sweep of Congress is a negative for the entire Healthcare Facilities sector as Republicans want to repeal the Affordable Care Act and cut spending. The analyst said the trend is towards less coverage, which will impact volumes and increase bad debt in general. Fishbeck lowered LifePoint's price target to $59 from $66 and expects 2017 EBITDA to be at the lower end of its 6-9x historical range given increased reimbursement risk.